This pattern indicates a gradual and statistically significant upregulation of Abca1 from postnatal day 70 onward, reaching its maximum at day 120, consistent with progressive molecular activation during ALS disease progression in the SOD1-G93A model. Here, ABCA1 is linked to amyotrophic lateral sclerosis.